Aureon Laboratories
About:
Aureon Laboratories focused on developing the advancement of predictive and personalized cancer treatment options.
Top Investors: Pfizer, Atlas Venture, Pfizer Venture Investments, New Leaf Venture Partners, Sprout Group
Description:
Aureon Laboratories is a life sciences company dedicated to enabling the advancement of predictive and personalized cancer treatment. Aureon provides objective, actionable information allowing patients and physicians to make more-informed treatment decisions through its prostate diagnostic tools.
Total Funding Amount:
$73.3M
Headquarters Location:
New York, New York, United States
Founded Date:
2001-01-01
Founders:
Jon Edelson
Number of Employees:
Last Funding Date:
2011-09-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai